Mr Charles H Miller, CRNA | |
530 Bogachiel Way, Forks, WA 98331-9120 | |
(360) 374-6271 | |
(360) 374-6238 |
Full Name | Mr Charles H Miller |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 530 Bogachiel Way, Forks, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326009481 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | AP30000657 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Charles H Miller, CRNA 38188 Fawn Rd Ne, Hansville, WA 98340-8793 Ph: (360) 638-0058 | Mr Charles H Miller, CRNA 530 Bogachiel Way, Forks, WA 98331-9120 Ph: (360) 374-6271 |
News Archive
IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.
Researchers at the Joslin Diabetes Center have identified for the first time two molecular pathways that are critical to activating a type of "good" fat found in the body, a discovery that could play an important role in the fight against obesity and diabetes.
Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases.
A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.
› Verified 4 days ago